Search
for
Sort by
Research 811–840 of 1000+
- New insights into the functions of Cox-2 in skin and esophageal malignancies
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Hypertrichosis lanuginosa acquisita following cytotoxic chemotherapy
- A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital
- Clinical Development of Topoisomerase-Interactive Drugs
- Present Chemotherapy Induced Alopecia and Research in Future
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Bioavailability File: Bicalutamide
- African Journal of Biomedical Research
- The concealed side of caspases: beyond a killer of cells
- The PDGF/PDGFR pathway as a drug target
- Pharmacological and Phytochemical Updates on Citrullus colocynthis & Citrullus lanata
- The Harmonies Played by TGF-β in Stem Cell Biology
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- Primary Cutaneous Rhabdoid Squamous Cell Carcinoma: A Case Report and Review of Molecular Features
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Targeting the Wnt pathways for therapies
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers
- Malignant epithelial tumors: Part II. Therapy and prevention
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor
- Dermatological adverse events with taxane chemotherapy
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Advances in dermatology research: A comprehensive literature review
- More than one way to skin . . .
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Epigenetic control of adult stem cell function